2m 2m 2m 2m 2m 2m 2m
PLIANT THERAPEUT (PLRX)
NASDAQ
$0.87-$0.02 (-2.35%)
Price as of Oct 22, 2026 7:30 PM EDT- $54.9MMarket Cap
- -51.06%1-Year Change
- BiotechnologyIndustry
PLIANT THERAPEUT (PLRX)
$0.87-$0.02 (-2.35%)
PLRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.89 | ||
Change | -$0.03 (-2.92%) | ||
Open | $0.93 | ||
High | $0.93 | ||
Low | $0.88 | ||
Previous Close | $0.91 | ||
Volume | 340,621 | ||
30-Day Average Volume | 387,396 | ||
1-Week Change | 0.21% | ||
1-Month Change | -20.20% | ||
1-Year Change | -51.06% | ||
3-Year Change | -93.51% | ||
5-Year Change | -94.87% | ||
Fundamentals | |||
Shares Outstanding | 61.9M | ||
Total Assets | $189.9M | ||
Market Cap | $54.9M | ||
Enterprise Value | $31.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$22.4M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$22.4M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $146.7M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue